Click on image to view larger version.

Figure 6 HRT Post-Infarction Risk Stratification

Cumulative mortality rates of patients stratified by HRT categories in the populations of MPIP (Multicenter Post-Infarction Program) (left), EMIAT (European Myocardial Infarction Amiodarone Trial) (middle), and ISAR-HRT (Innovative Stratification of Arrhythmic Risk HRT) studies (right). The numbers of patients in the individual groups involved in the analyses at 0, 6, 12, 18, and 24 months are shown under each graph. Data for the MPIP and EMIAT studies are from Schmidt et al. (1) and for the ISAR-HRT study from Barthel et al. (92). Abbreviations as in Figure 1.